These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31750832)

  • 1. Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870.
    Zhou Y; Cao C; He L; Wang X; Zhang XC
    Elife; 2019 Nov; 8():. PubMed ID: 31750832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of DRD4 bound to an agonist and an antagonist using in silico approaches.
    Jatana N; Thukral L; Latha N
    Proteins; 2015 May; 83(5):867-80. PubMed ID: 25371112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor.
    Ericksen SS; Cummings DF; Teer ME; Amdani S; Schetz JA
    J Pharmacol Exp Ther; 2012 Aug; 342(2):472-85. PubMed ID: 22588261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting.
    Jatana N; Thukral L; Latha N
    J Mol Model; 2016 Jan; 22(1):14. PubMed ID: 26680992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat.
    Ukai M; Mitsunaga H
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):645-9. PubMed ID: 16357950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of rare variants in human dopamine receptor D4 gene by genotype-phenotype correlations.
    Michealraj KA; Jatana N; Jafurulla ; Narayanan L; Chattopadhyay A; Thelma BK
    Neuroscience; 2014 Mar; 262():176-89. PubMed ID: 24406443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D4 receptor antagonist inhibits melanogenesis through transcriptional downregulation of MITF via ERK signalling.
    Jung JM; Kim SY; Lee WJ; Hwang JS; Chang SE
    Exp Dermatol; 2016 Apr; 25(4):325-8. PubMed ID: 26782007
    [No Abstract]   [Full Text] [Related]  

  • 8. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.
    Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jan; 9(1):97-102. PubMed ID: 9990464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.
    Kulagowski JJ; Broughton HB; Curtis NR; Mawer IM; Ridgill MP; Baker R; Emms F; Freedman SB; Marwood R; Patel S; Patel S; Ragan CI; Leeson PD
    J Med Chem; 1996 May; 39(10):1941-2. PubMed ID: 8642550
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
    Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI
    J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats.
    Yan Y; Pushparaj A; Le Strat Y; Gamaleddin I; Barnes C; Justinova Z; Goldberg SR; Le Foll B
    Neuropsychopharmacology; 2012 Feb; 37(3):685-96. PubMed ID: 22030716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
    Schetz JA; Benjamin PS; Sibley DR
    Mol Pharmacol; 2000 Jan; 57(1):144-52. PubMed ID: 10617689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dopamine D4 receptor ligands on operant alcohol self-administration and cue- and stress-induced reinstatement in rats.
    Kim A; Di Ciano P; Pushparaj A; Leca J; Le Foll B
    Eur J Pharmacol; 2020 Jan; 867():172838. PubMed ID: 31794709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modeling, molecular dynamic simulation, and docking based binding site analysis of human dopamine (D4) receptor.
    Khoddami M; Nadri H; Moradi A; Sakhteman A
    J Mol Model; 2015 Feb; 21(2):36. PubMed ID: 25650117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).
    Löber S; Hübner H; Utz W; Gmeiner P
    J Med Chem; 2001 Aug; 44(17):2691-4. PubMed ID: 11495580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356.
    Bergauer M; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1937-40. PubMed ID: 12113813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.
    Cummings DF; Ericksen SS; Goetz A; Schetz JA
    J Pharmacol Exp Ther; 2010 Jun; 333(3):682-95. PubMed ID: 20215412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D
    Wang S; Wacker D; Levit A; Che T; Betz RM; McCorvy JD; Venkatakrishnan AJ; Huang XP; Dror RO; Shoichet BK; Roth BL
    Science; 2017 Oct; 358(6361):381-386. PubMed ID: 29051383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.
    Mammoli V; Bonifazi A; Dal Ben D; Giannella M; Giorgioni G; Piergentili A; Pigini M; Quaglia W; Thomas A; Newman AH; Ferré S; Sanchez-Soto M; Keck TM; Del Bello F
    ChemMedChem; 2016 Aug; 11(16):1819-28. PubMed ID: 26990230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist.
    Enguehard-Gueiffier C; Hübner H; El Hakmaoui A; Allouchi H; Gmeiner P; Argiolas A; Melis MR; Gueiffier A
    J Med Chem; 2006 Jun; 49(13):3938-47. PubMed ID: 16789750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.